Urogynecology (Hagerstown, Md.)最新文献

{"title":"Prophylactic Midurethral Slings at the Time of Pelvic Organ Prolapse Repair.","authors":"Emir Gurbuz, Tamutenda Chidawanyika, Esra Uyanik, Savci B Telek, Oz Harmanli","doi":"10.1097/SPV.0000000000001942","DOIUrl":"https://doi.org/10.1097/SPV.0000000000001942","url":null,"abstract":"<p><strong>Importance: </strong>Prophylactic midurethral sling (MUS) placement can prevent de novo stress urinary incontinence (SUI) after pelvic organ prolapse (POP) repair, but the concern about additional MUS-related adverse events remains.</p><p><strong>Objective: </strong>The objective of this study was to compare postoperative outcomes between women with and without preoperative SUI after undergoing concomitant POP repair and MUS placement.</p><p><strong>Study design: </strong>This retrospective cohort study included women undergoing POP repair with concurrent MUS placement between 2017 and 2023. Patients in the prophylactic group did not have preoperative SUI, whereas those in the nonprophylactic group did. The primary outcome was postoperative SUI. Secondary outcomes included recurrent urinary tract infection (UTI), voiding difficulty, overactive bladder symptoms, pelvic pain, and mesh complications. Multivariate logistic regression was used to adjust for potential confounders.</p><p><strong>Results: </strong>Of 1,132 women, there were 409 (36.1%) prophylactic and 723 (63.9%) nonprophylactic MUS procedures. Women in the prophylactic group were significantly older, predominantly postmenopausal, of lower body mass index, and more commonly had stage 3 POP and underwent sacrocolpopexy. Median follow-up was 12 months. Postoperative SUI occurred less frequently in the prophylactic group (1.7% vs 5.8%; P=0.001). Women with a prophylactic MUS were nearly 3 times less likely to have postoperative SUI (adjusted odds ratio, 0.31; 95% CI, 0.14-0.72). Postoperative recurrent UTIs were less common in the prophylactic group (1.5% vs 4.4%; P=0.008), whereas other adverse events were comparable between groups.</p><p><strong>Conclusions: </strong>Women without preoperative SUI had lower rates of postoperative SUI after concomitant POP repair and MUS placement, with similar rates of adverse events.</p>","PeriodicalId":75288,"journal":{"name":"Urogynecology (Hagerstown, Md.)","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149229488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Chronic Anticoagulation Increases Complications in Obliterative Prolapse Surgery.","authors":"Stephanie W Zuo, Brigid S Mumford, Halina M Zyczynski, Mary F Ackenbom","doi":"10.1097/SPV.0000000000001937","DOIUrl":"https://doi.org/10.1097/SPV.0000000000001937","url":null,"abstract":"<p><strong>Importance: </strong>Chronic anticoagulation has been identified as a risk factor for postoperative complications in other specialties, but there is a paucity of data on its effect on older women undergoing obliterative prolapse repair.</p><p><strong>Objective: </strong>The objective of this study was to assess whether chronic anticoagulation is associated with increased serious adverse events (SAEs) after obliterative prolapse surgery.</p><p><strong>Study design: </strong>This was a retrospective cohort analysis of women 65 years or older undergoing obliterative prolapse repair at 2 academic institutions from 2016 to 2023. Patients were identified by Current Procedural Terminology (CPT) code and grouped by preoperative chronic anticoagulation status. The composite primary outcome was defined as SAE within 8 weeks of surgery. Multivariable logistic regression was performed, controlling for relevant variables with P <0.10 on univariate analysis.</p><p><strong>Results: </strong>Among the 777 older women who underwent obliterative surgery, 97 (12.5%) were chronically anticoagulated. The most commonly used anticoagulants were apixaban (n = 37, 38.1%) and clopidogrel (n = 31, 32%), with 21.7% reporting concomitant use of aspirin. Anticoagulated individuals were more likely to be current smokers and to have a history of venous thromboembolism, myocardial infarction, and stroke (P < 0.05). Chronically anticoagulated women had 1.72 times greater adjusted odds of experiencing SAE (95% CI, 1.02-2.91). Chronic anticoagulation was associated with an increased incidence of readmission, cardiac complications, transfusion, hematoma, and organ-space surgical site infection (P < 0.05). Rates of SAEs were highest in individuals taking rivaroxaban (35.7%) and those taking concomitant aspirin (38.1%).</p><p><strong>Conclusions: </strong>Chronic anticoagulation is associated with increased odds of SAE in older women undergoing obliterative prolapse surgery. Physicians should consider this additional risk in surgical decision making and counseling on anticoagulant suspension and resumption perioperatively.</p>","PeriodicalId":75288,"journal":{"name":"Urogynecology (Hagerstown, Md.)","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149198361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Polymers for Pelvic Floor Repair: Current State and Future Prospects.","authors":"Hannah Spece, Sandhya A Varghese, Amanda M Artsen, Pamela A Moalli","doi":"10.1097/SPV.0000000000001936","DOIUrl":"https://doi.org/10.1097/SPV.0000000000001936","url":null,"abstract":"<p><strong>Importance: </strong>Surgical repair of pelvic organ prolapse and stress urinary incontinence frequently relies on polymeric biomaterials in sutures, meshes, and membranes to provide structural support during tissue healing and beyond. Polypropylene has long served as the default material owing to its strength, durability, and processability, but the chronic foreign body response and mechanical mismatch between stiff implants and viscoelastic pelvic tissue have been linked to complications, including mesh contraction, exposure, and dyspareunia. These limitations, together with regulatory actions on transvaginal mesh, have driven interest in alternative permanent polymers and, increasingly, in resorbable materials designed to provide temporary reinforcement during tissue remodeling.</p><p><strong>Objective: </strong>The objective of this review was to summarize the characteristics, advantages, and limitations of polymers currently used or under investigation for load-bearing and reinforcement urogynecologic implants.</p><p><strong>Study design: </strong>This is a narrative review of polymeric biomaterials for urogynecologic mesh, membrane, and suture applications, based on a search of PubMed and Web of Science for in vitro and in vivo studies of polymer-based devices.</p><p><strong>Results: </strong>Permanent materials covered include polypropylene, polyvinylidene fluoride, polytetrafluoroethylene, polyethylene terephthalate, polyamide, and polyurethane. Resorbable materials include lactide- and caprolactone-based polyesters, polydioxanone, polyhydroxyalkanoates (notably poly-4-hydroxybutyrate), and natural polymers such as silk fibroin, bacterial cellulose, and collagen. The use of advanced manufacturing techniques and functionalizing strategies to improve tissue reinforcement and healing is also highlighted.</p><p><strong>Conclusions: </strong>The review provides a reference point for the design of next-generation urogynecologic implants, which requires integrated consideration of polymer properties, scaffold architecture, and host biology across the course of tissue remodeling.</p>","PeriodicalId":75288,"journal":{"name":"Urogynecology (Hagerstown, Md.)","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149198290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Short-Term Medicare-Allowed Amounts Associated With Initial Treatments for Stress Urinary Incontinence: Analysis of a Large National Medicare Fee-for-Service Claims Database.","authors":"Tyler M Muffly, Jerry L Lowder, Tanaz Ferzandi, Gabriela E Halder, Evelyn F Hall, Mary V Baker, Mikio Nihira, Simon P Patton, Shannon L Wallace, Joseph Panza, Daniel H Biller","doi":"10.1097/SPV.0000000000001930","DOIUrl":"https://doi.org/10.1097/SPV.0000000000001930","url":null,"abstract":"<p><strong>Importance: </strong>Limited data describe short-term Medicare-allowed amounts associated with treatments for stress urinary incontinence (SUI).</p><p><strong>Objective: </strong>The objective of this study was to compare total Medicare-allowed amounts for pelvic floor muscle therapy (PFMT), pessary, and sling surgery as the first SUI treatments observed.</p><p><strong>Study design: </strong>We analyzed 5% Medicare fee-for-service claims from 2008 through 2016 for women aged 66 years or older with SUI or mixed urinary incontinence. Episode allowed amounts were summed for 90 days after PFMT or pessary treatment and 180 days after sling surgery, adjusted to 2016 dollars, and modeled using log-linear regression.</p><p><strong>Results: </strong>Among 16,695 beneficiaries (median age: 76 y; 92.9% White), 46.2% received pessary, 33.3% PFMT, and 20.5% sling surgery. From 2008 to 2016, PFMT increased from 24.8% to 43.5% of observed treatments, whereas sling surgery decreased from 27.9% to 9.8% (P<0.01 for both). Median total allowed amounts were $654 (IQR, $327-$1,340) for PFMT over 90 days, $766 (IQR, $458-$1,244) for pessary over 90 days, and $3,663 (IQR, $1,511-$4,173) for sling over 180 days. Facility-related amounts represented 73% of aggregate sling allowed amounts. Compared with pessary, sling was associated with a 3.3-fold higher allowed amount. Clinician specialty, urinary tract infection, geographic region, and Medicare-only coverage were independently associated with allowed amounts.</p><p><strong>Conclusions: </strong>Short-term Medicare-allowed amounts varied by treatment, specialty, and region. Because observation windows differed and the data are historical, these estimates are treatment-specific benchmarks rather than current head-to-head comparisons.</p>","PeriodicalId":75288,"journal":{"name":"Urogynecology (Hagerstown, Md.)","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149139592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Utilization, Safety, and Outcomes of Virtual Care for Urinary Tract Infections.","authors":"Ghanshyam S Yadav, Heidi W Brown, Janice Wong, Shawn Menefee, Jasmine Tan-Kim","doi":"10.1097/SPV.0000000000001940","DOIUrl":"https://doi.org/10.1097/SPV.0000000000001940","url":null,"abstract":"<p><strong>Importance: </strong>The effects of increasing virtual care for urinary tract infections (UTIs) are unknown.</p><p><strong>Objective: </strong>The objective of this study was to compare factors associated with and outcomes following virtual versus in-person UTI care.</p><p><strong>Study design: </strong>This retrospective cohort identified all outpatient UTI encounters among adult women in a regional health system from 2015 to 2022. Virtual versus in-person visit, age, body mass index, self-identified race and ethnicity, median household income, Neighborhood Deprivation Index (NDI), Elixhauser Comorbidity Index (ECI), and UTI-related 30-day outcomes (hospitalization, emergency department [ED] visit, follow-up encounter) were extracted. Multivariate logistic regression identified factors associated with virtual versus in-person care and 30-day outcomes.</p><p><strong>Results: </strong>Sixty percent of 1,220,698 outpatient UTI encounters were virtual. Increasing income and age younger than 50 years were associated with the highest adjusted odds of virtual UTI care. Speaking Spanish or a language other than English and less deprived NDI were associated with lower odds of virtual care. There were 9,237 (0.8%) UTI-related hospitalizations, 20,680 (1.7%) UTI-related ED visits, and 279,668 (22.9%) additional outpatient encounters within 30 days, and all were less frequent following a virtual versus an in-person index UTI encounter. Age, ECI, and NDI were strongly associated with subsequent care utilization in multivariable models. A virtual index UTI encounter was associated with lower adjusted odds of an ED visit and higher adjusted odds of an additional outpatient encounter within 30 days.</p><p><strong>Conclusions: </strong>Sociodemographic characteristics differ between those who access virtual versus in-person UTI care. Age, ECI, and social determinants of health are strong predictors of subsequent care within 30 days.</p>","PeriodicalId":75288,"journal":{"name":"Urogynecology (Hagerstown, Md.)","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149139635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cost-Minimization Analysis of Stress Urinary Incontinence Treatment Strategies.","authors":"Shannon L Wallace, Tyler M Muffly, Daniel H Biller, Mary V Baker, Tanaz Ferzandi, Gabriela E Halder, Evelyn F Hall, Simon P Patton, Joseph Panza, Mikio Nihira, Jerry L Lowder","doi":"10.1097/SPV.0000000000001931","DOIUrl":"https://doi.org/10.1097/SPV.0000000000001931","url":null,"abstract":"<p><strong>Importance: </strong>Stress urinary incontinence (SUI) imposes a substantial burden on patients and the health care system. Understanding cost differences among common treatment strategies can inform efficient, evidence-based care models.</p><p><strong>Objectives: </strong>The objective of this study was to evaluate and compare the 1-year costs associated with 3 initial treatment strategies for SUI: pelvic floor muscle therapy (PFMT), vaginal pessary, and sling surgery.</p><p><strong>Study design: </strong>This was a retrospective cost-minimization analysis using a decision-tree model informed by a 5% national Medicare Fee-For-Service claims data set (2008-2016). Costs were calculated from a payer perspective and included all care within 6 months before and after the index treatment. One-year costs were also projected using a simplified American Urological Association (AUA) guideline-based pathway. Tornado analyses identified key cost drivers.</p><p><strong>Results: </strong>Of 16,695 patients, 46% received a pessary, 33.3% PFMT, and 20.5% sling surgery. Downstream sling utilization occurred in 5.6% of PFMT, 4.2% of pessary, and 3.1% of sling patients. Median 12-month costs were $2,346.79 (PFMT), $2,539.48 (pessary), and $5,517.16 (sling). Mean costs were $3,358.43 (PFMT), $3,171.94 (pessary), and $6,581.74 (sling). AUA-guideline-based pathway yielded $1,391.79 (PFMT), $1,430.48 (pessary), and $4,753.81 (sling). Cost drivers varied by treatment, including complications, bladder diagnostics, and downstream surgery.</p><p><strong>Conclusions: </strong>At 1 year, sling surgery is the costliest first-line strategy for SUI. Pessary and PFMT demonstrate lower average costs. These findings support cost-conscious, evidence-based care pathways that prioritize conservative management as initial therapy, while acknowledging that cost minimization does not capture effectiveness or durability. Future research incorporating longer time horizons, bulking agents, and prospective utility measurement is needed for a full cost-effectiveness evaluation.</p>","PeriodicalId":75288,"journal":{"name":"Urogynecology (Hagerstown, Md.)","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149139555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluation of Health State Utility for Pelvic Organ Prolapse by Stage.","authors":"Nicholas Scioscia, Bryna J Harrington, Barbara Ha, Lauren King, Dhananjay Vaidya, Victoria Handa, Chi Chiung Grace Chen, Joan Blomquist, Stephanie Jacobs, Danielle Patterson","doi":"10.1097/SPV.0000000000001939","DOIUrl":"https://doi.org/10.1097/SPV.0000000000001939","url":null,"abstract":"<p><strong>Importance: </strong>An accurate measure of health state utility is needed to perform economic evaluations surrounding the management of pelvic organ prolapse.</p><p><strong>Objective: </strong>The objective of this study was to obtain a health state utility measure for different stages of pelvic organ prolapse using healthy volunteers.</p><p><strong>Study design: </strong>In this observational study, health state descriptions were first developed following an expert panel review completed in conjunction with a series of pilot interviews. They include a standardized symptom description along with representative figures of a particular stage. Participants were assigned to assess one stage of pelvic organ prolapse. After reviewing the health state description, volunteers completed the standard gamble interview (SG) and EuroQoL 5-Dimension (EQ-5D) questionnaire to calculate the utility of each health state.</p><p><strong>Results: </strong>One hundred seventeen individuals (117) were included in the final analysis; 39 individuals were analyzed for each stage. When using the SG technique, differences in the health utility measure (IQR) obtained at various stages of pelvic organ prolapse were not statistically significant [stage 2, 0.82 (0.68, 0.97); stage 3, 0.82 (0.65, 0.93); stage 4, 0.80 (0.60, 0.90); P=0.098]. With the SG as the referent, the health utility measure using generic measures (EQ-5D and visual analog scale) was significantly lower across all stages.</p><p><strong>Conclusions: </strong>This study defines the health state utility for stages 2, 3, and 4 pelvic organ prolapse directly using the standard gamble interview approach among healthy volunteers. These values can be used in the completion of future economic evaluations surrounding the management of patients with symptomatic pelvic organ prolapse.</p>","PeriodicalId":75288,"journal":{"name":"Urogynecology (Hagerstown, Md.)","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149139639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Patient Experience With Office-Based Polyacrylamide Hydrogel Injection.","authors":"Amanda Chapa, Emma Wittman, Bradley Schroeder, Patrina Agosta, Douglass Hale, Jennifer Hamner, Ramzy Burns","doi":"10.1097/SPV.0000000000001933","DOIUrl":"https://doi.org/10.1097/SPV.0000000000001933","url":null,"abstract":"<p><strong>Importance: </strong>Stress urinary incontinence (SUI) is prevalent and has a significant effect on quality of life. Urethral bulking with polyacrylamide hydrogel (PAHG) provides a minimally invasive treatment option for SUI caused by intrinsic sphincter deficiency. However, limited data exist evaluating patient experience with in-office PAHG injection performed without sedation.</p><p><strong>Objectives: </strong>The objectives of this study were to compare anticipated and experienced pain with in-office PAHG injection under local anesthesia and to assess patient satisfaction with the procedure.</p><p><strong>Study design: </strong>This prospective study included patients undergoing in-office PAHG injection. Participants completed a visual analog scale (VAS) assessing anticipated pain before the procedure and pain experienced afterward. Participants were contacted within 1 week to assess satisfaction. The change in VAS score was calculated to evaluate differences between anticipated and experienced pain.</p><p><strong>Results: </strong>Forty patients participated in the study with a median age of 49 years and mean body mass index of 32.7. The median anticipated and experienced VAS pain scores were 5.15 (3.40, 7.90) and 7.00 (5.90, 8.95), respectively, corresponding to a median increase of 1.50 (-0.35, 2.85, P=0.002). Most participants reported they would be willing to undergo the procedure again. There was no statistically significant difference in the change in VAS score based on satisfaction with the procedure.</p><p><strong>Conclusions: </strong>Participants reported greater discomfort than anticipated with in-office PAHG injection; however, most remained satisfied with the procedure and would be willing to undergo it again. These findings support the feasibility and acceptability of office-based PAHG injection while emphasizing the importance of preprocedure counseling regarding expected discomfort.</p>","PeriodicalId":75288,"journal":{"name":"Urogynecology (Hagerstown, Md.)","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2026-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149119648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Away Rotations and Urogynecology Fellowship Match: A Retrospective Study.","authors":"Anna Guanzon, Libby Ratliff, Paige Schultheis, Douglass Hale, Surya S Bhamidipalli, David Guise, Jennifer Hamner, Michael Heit","doi":"10.1097/SPV.0000000000001848","DOIUrl":"10.1097/SPV.0000000000001848","url":null,"abstract":"<p><strong>Importance: </strong>Whether performing an away rotation increases fellowship match success is important for both cost and logistic considerations.</p><p><strong>Objective: </strong>This study aimed to determine whether away rotations increase the likelihood of urogynecology and pelvic reconstructive surgery (URPS) match success.</p><p><strong>Study design: </strong>This was a retrospective analysis of 246 applications to Indiana University URPS fellowship between 2015 and 2019. Variables included match success, whether an away rotation was performed, demographic data, medical school and residency descriptors, examination scores, prior research, personal statements and letters of recommendation. Data were summarized for the overall cohort and by URPS match (yes/no). The t test was used to compare continuous variables with normal distributions, the Wilcoxon rank sum test for nonnormal distributions, and the χ 2 test for categorical variables. Univariate logistic regression was performed to test the association of each variable collected with the URPS match. Backward selection was used to determine variables to include in multivariable logistic regression and identify independent predictors of URPS match success.</p><p><strong>Results: </strong>Of the 245 applicants for whom match data were available, 80 performed a URPS away rotation and 171 (69.8%) successfully matched into a URPS fellowship. Approximately 34% (33.9%) who matched performed a URPS away rotation versus 30.1% ( P value 0.57) who did not. Successful match applicants were younger (adjusted OR, 0.82; 95% CI, 0.73, 0.92), had presented at a URPS-related scientific meeting (adjusted OR, 2.53; 95% CI, 1.25-5.13), and had higher personal statement scores (adjusted OR, 1.11; 95% CI, 1.01-1.21).</p><p><strong>Conclusions: </strong>URPS away rotations do not increase the likelihood of match success. Conducting URPS research is likely a more productive focus.</p>","PeriodicalId":75288,"journal":{"name":"Urogynecology (Hagerstown, Md.)","volume":" ","pages":"1233-1240"},"PeriodicalIF":1.2,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147679325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Response to Letter to the Editor re: \"Factors Associated With Persistent Bothersome Urinary Symptoms and Leakage After Pregnancy\".","authors":"Sonia Bhandari Randhawa, Andrea Rizkallah, David B Nelson, Elaine L Duryea, Catherine Y Spong, Jessica E Pruszynski, David D Rahn","doi":"10.1097/SPV.0000000000001903","DOIUrl":"10.1097/SPV.0000000000001903","url":null,"abstract":"","PeriodicalId":75288,"journal":{"name":"Urogynecology (Hagerstown, Md.)","volume":" ","pages":"1299-1300"},"PeriodicalIF":1.2,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148335157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}